NCT03085043View on ClinicalTrials.gov

Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

April 20, 2016

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Prostate Carcinoma
Interventions
PROCEDURE

Bone Scan

Undergo bone scan

PROCEDURE

Computed Tomography

Undergo CT of the abdomen and pelvis

PROCEDURE

Magnetic Resonance Imaging

Undergo pelvic MRI

PROCEDURE

Magnetic Resonance Whole Body Diffusion-Weighted Imaging

Undergo magnetic resonance whole body diffusion-weighted imaging

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03085043 - Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer | Biotech Hunter | Biotech Hunter